Q3 2024 PEMGARDA™ (pemivibart) net product revenue of $9.3 million; Invivyd ended Q3 2024 with $106.9 million in cash and cash equivalentsTargets ...

We initiated our '24-'25 COVID-19 commercial season in mid-September shortly after achieving ... including both KP.3.1.1 and ...

The second booster was recommended to address the omicron variant XEC rising as a fast-spreading variant slated to take over ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Since 2020, COVID-19 has surged across the nation and the world ... The latest coronavirus strain, XEC, makes up 17%. It is ...

The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...

As of late October, the CDC recommends a second dose of the 2024-2025 COVID-19 vaccine for at-risk groups. Here's what you ...

But what kind of sickness do your symptoms point to? Here's a breakdown for COVID-19, flu and more — and why testing is so ...

S eniors and people who are immunocompromised should get not just one but two COVID-19 shots this respiratory virus season. That's the new recommendation from the U.S. Centers for Disease Control and ...

By Jack Phillips Contributing Writer Recent estimates published by the U.S. Centers for Disease Control and Prevention show ...